Abstract

In 1980, Mirowski et al1 implanted the first implantable cardioverter-defibrillator (ICD) in a young female with recurrent ventricular fibrillation and provided an innovative approach to aborted sudden cardiac death (SCD). Although the ICD was considered a treatment of last resort during that incipient stage, subsequent years have witnessed prolific expansion of indications for ICD implantation.2 Several large-scale clinical trials have demonstrated its efficacy for both primary and secondary prevention of SCD in patients with ischemic and nonischemic cardiomyopathy.3,4 ICD therapy in such high-risk patients has been shown to improve survival compared with conventional antiarrhythmic drug therapy alone.3,4 The number of ICD implantations has increased significantly in the last decade, with a concurrent decrease in the use of stand-alone antiarrhythmic drugs for ventricular indications.5–7 Current ICDs have sophisticated programming capabilities, atrial and bipolar leads, and are able to deliver antitachycardia pacing algorithms (ATP) in addition to defibrillating shocks. Response by Kuck on p 705 Typically, patients who receive ICDs are at high risk for recurrent arrhythmia; hence, most patients receive 1 or more ICD therapies for spontaneous arrhythmias after implantation.3 Despite the technological evolution of ICD systems, more than 20% of shocks are due to supraventricular arrhythmia and hence are inappropriate.8–10 The ICD uses ATP or defibrillating shocks to terminate episodes of ventricular tachycardia (VT) or ventricular fibrillation (VF). Although the ICD aborts VT/VF, many patients continue to have symptoms such as dizziness, palpitations, nervousness, flushing, or syncope before receiving an ICD shock.11 When the shock is finally delivered, it is physically and emotionally painful and so noxious that 23% of patients dread shocks and 5% of patients prefer to do without an ICD and “take their chances.”12 A significant prevalence of sadness, depression, and even anxiety disorders have been reported after …

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call